MISSION

Restech offers minimally invasive tools to multiple specialties in order to accurately diagnose and manage reflux, and will continue to create solutions related to the complexity of the aerodigestive system.

VISION

Restech’s diagnostic tools will evolve the standard of care for patients with reflux, providing physicians with the necessary data to transform the algorithm of care for millions of patients.

Restech Executive Team


Debra Krahel

Debra Krahel, President, CEO

With over 20 years of executive experience in both the private and public sector, Debra brings a broad understanding of healthcare delivery system. With experience managing products aimed at wide scale disease and population management for 20 million subscribers, Debra has extensive experience in effectively and efficiently developing models of delivery that address specific health issues. Debra has also been involved in the legislative process and served as the elected President of the Independent Physician Association of California. Debra is dedicated to bringing tools to the healthcare market that improve and support the clinical process.


Leo Roucher

Leo Roucher, Founder, Chairman, CTO

With nearly 30 years of working with physician thought leaders developing novel and emerging technologies, Leo has played a key role in the development and evolution of balloon angioplasty and stent technologies that revolutionized the therapy of cardiac disease. His experience was instrumental in the development of the patented platform technology which drives the Restech sensor. Leo provides a vision and passion for effecting change in the diagnosis and management of atypical reflux.


Jeffery Schipper

Jeff Schipper, Co-Founder, Director

Jeff has a breadth of experience with over 25 years in engineering and executive positions within major fortune 100 healthcare companies. He also has proven success in startup medical technology companies. Jeff provides leadership in securing and managing Restech’s patent portfolio. He also built Restech’s compliance platform that established regulatory acceptance in 25+ countries worldwide. Jeff’s scientific support and in-depth understanding of the device industry set the foundation for current and future commercial innovations at Restech.

Board of Directors


Leo Roucher, Founder, Chairman, CTO

With nearly 30 years of working with physician thought leaders developing novel and emerging technologies, Leo has played a key role in the development and evolution of balloon angioplasty and stent technologies that revolutionized the therapy of cardiac disease. His experience was instrumental in the development of the patented platform technology which drives the Restech sensor. Leo provides a vision and passion for effecting change in the diagnosis and management of atypical reflux.


Wayne Yamamoto

Mr. Yamamoto has a successful record of executive management leading companies through rapid growth over the last 27 years. Mr. Yamamoto serves on the Board of Directors for Restech and acts as CEO for Securesoft Systems, an enterprise compliance and risk management solutions company for the Healthcare market.


Ron Hadani

Mr. Hadani is Founder and CEO of Nanamed, a medical device company headquartered in New Jersey. Prior to this he spent nearly a decade as the President and CEO of a publicly traded endoscopy company. With over twenty-five years of industry knowledge and experience, Mr. Hadani provides Restech with a unique understanding of the medical device market. He holds a Master of Science degree in Electrical and Computer Engineering.


Paul Johnson

Paul B. Johnson is a partner with the full service law firm Procopio (Procopio, Cory, Hargreaves & Savitch LLP) Mr. Johnson has counseled some of the most successful technology companies in acquisitions, public and private securities offerings, Securities and Exchange Commissions compliance and general corporate governance. Paul’s practice focuses on buy and sell-side mergers and acquisitions, venture capital investments, securities offering and compliance, start up companies and general business counseling. He is also experienced in guiding a number of smaller companies through important events in the life cycle, including capital and angel financings, and sell-side mergers and acquisitions.


Jeff Schipper, Co-Founder, Director

Jeff has a breadth of experience with over 25 years in engineering and executive positions within major fortune 100 healthcare companies. He also has proven success in startup medical technology companies. Jeff provides leadership in securing and managing Restech’s patent portfolio. He also built Restech’s compliance platform that established regulatory acceptance in 25+ countries worldwide. Jeff’s scientific support and in-depth understanding of the device industry set the foundation for current and future commercial innovations at Restech.


John Hanks

Mr. Hanks is professor of practice in the Department of Biomedical Engineering and director of industry relations for the Center for Remote Health Technologies and Systems at Texas A&M University. Professor Hanks is an industry veteran with more than 25 years of corporate experience at National Instruments and Siemens Medical Systems. He brings a wealth of industry knowledge, engineering and product management, intellectual property negotiations and licensing, and commercialization experience to Restech.

John Hanks is professor of practice in the Department of Biomedical Engineering and director of industry relations for the Center for Remote Health Technologies and Systems (CRHTS). Professor Hanks is an industry veteran with more than 25 years of corporate experience at National Instruments and Siemens Medical Systems. While at National Instruments he held positions as vice president of life sciences and healthcare and vice president of industrial and embedded products. As vice president of life sciences and healthcare, Hanks led teams that developed commercial subsystems and prototype optical coherence tomography imaging, mass spectrometry, DNA sequencing and molecular diagnostics devices. In addition, as vice president of industrial and embedded products he led efforts to bring wireless sensor network, data acquisition, computer vision, motion control, and field programmable gate array-based embedded measurement and control software and hardware products to market. Professor Hanks brings a wealth of industry knowledge, engineering and product management, intellectual property negotiations and licensing, and commercialization experience to the department.

Advisory Board


Tom R. DeMeester

Tom R. DeMeester, MD

Tom R. DeMeester, MD, is renowned for his work in foregut and pulmonary disease. He is the originator and developer of the field of noninvasive foregut ambulatory monitoring, and has made several key contributions to the understanding of the physiology and pathophysiology of diseases of the esophagus and their surgical correction. He has over 430 publications in peer reviewed journals, 161 book chapters, 9 books and several videos and motion pictures to his credit. Dr. DeMeester is a Professor of Thoracic Surgery Chairman in the Department of Surgery, Keck School of Medicine, University of Southern California.


Robert Thayer Sataloff

Robert Thayer Sataloff, MD, DMA, FACS

Robert Thayer Sataloff, MD, DMA, FACS is a professor and chairman, Department of Otolaryngology-Head and Neck surgery and senior associate, Dean for Clinical Academic Specialties, Drexel University College of Medicine. He is also adjunct professor in the departments of otolaryngology – Head and Neck Surgery at Thomas Jefferson University, The University of Pennsylvania and Temple University; on the faculty of the academy of vocal arts; and conductor of the Thomas Jefferson University.


Philip O. Katz

Philip O. Katz, MD

Philip O. Katz, MD is located at the Einstein Healthcare Network in Philadelphia where he operates his state-of-the-art esophageal testing laboratory and is developing an active clinical and research practice in the area. His research interests include all aspects of gastro-esophageal reflux disease, including nocturnal recovery of gastric acid secretion during proton pump inhibitor therapy and esophageal pain perception. Dr. Katz is an editorial reviewer for Annals of Internal Medicine, American Journal of Gastroenterology, Gastroenterology, Journal of the American Geriatric Association, and Digestive Diseases and Sciences. He has contributed to the publication of over 120 peer-reviewed papers, numerous abstracts, books, book chapters, and monographs.


George Triadafilopoulos

George Triadafilopoulos, MD

George Triadafilopoulos, MD, is a board Certified Gastroenterologist and Internist who is Clinical Professor of Medicine, at the Division of Gastroenterology and Hepatology, Stanford University School of Medicine. Dr. Triadafilopoulos’s research activity ranges from gastroesophageal reflux disease and Barrett’s esophagus, to NSAID-induced gastropathy, colon polyps, C.difficile colitis, and irritable bowel syndrome.


Craig Zalvan

Craig Zalvan, MD

Craig Zalvan, MD, is the Medical Director of the Institute for Voice and Swallowing Disorders at Phelps Memorial Hospital Center in Sleepy Hollow, New York. A board certified otolaryngologist, Dr. Zalvan received his medical degree from Albert Einstein College of Medicine and trained at Manhattan Eye, Ear and Throat Hospital, Columbia Presbyterian, New York Hospital, Memorial Sloan Kettering Cancer Center, and St. Lukes/Roosevelt where he participated in a laryngology/voice and swallow fellowship.


Lee M. Akst

Lee M. Akst, MD

Lee M. Akst, MD is an Assistant Professor and Director of the Johns Hopkins Voice Center in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery. Dr. Akst completed medical school at Yale University, otolaryngology residency at the Cleveland Clinic Foundation, and laryngology fellowship at the Massachusetts General Hospital Center for Laryngeal Surgery and Voice Rehabilitation. Prior to joining Johns Hopkins, Dr. Akst had been the Director of the Voice Center at Loyola University Chicago Stritch School of Medicine. His clinical interests are in care of patients with voice and swallowing disorders, with a focus on office-based procedures and microlaryngeal surgery.